![Vimal Srivastava](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vimal Srivastava
Corporate Officer/Principal bij
ULTRAGENYX PHARMACEUTICAL INC.
Profiel
Vimal Srivastava is Senior VP-Development & Alliance Management at Ultragenyx Pharmaceutical, Inc. since 2018.
Former positions include Director-Program Management at BioMarin Pharmaceutical, Inc. in 2005, Senior Director-Portfolio & Project Management at Janssen Alzheimer Immunotherapy in 2011, and Global Manager-Program at Amgen, Inc. in 2008.
Education includes graduate degrees from The Johns Hopkins University and St. John's University, and an undergraduate degree from Banaras Hindu University.
Actieve functies van Vimal Srivastava
| Bedrijven | Functie | Begin |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 21-11-2011 |
Eerdere bekende functies van Vimal Srivastava
| Bedrijven | Functie | Einde |
|---|---|---|
Janssen Alzheimer Immunotherapy | Corporate Officer/Principal | 01-01-2011 |
| AMGEN INC. | Corporate Officer/Principal | 01-01-2008 |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01-01-2005 |
Opleiding van Vimal Srivastava
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
71
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. John's University
 St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Banaras Hindu University
 Banaras Hindu University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Alzheimer Immunotherapy |
Kies MarketScreener 
